7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine

C70H88F4N30O7 — CID 167610606

IUPAC7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine
SMILESCCCOc1ccc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)nc1.CCCOc1ncc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)cc1C(F)(F)F.[2H]C([2H])([2H])OCCOc1cnc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)c(F)c1
InChIInChI=1S/C24H29F3N10O2.C23H29FN10O3.C23H30N10O2/c1-3-11-38-21-17(24(25,26)27)13-16(15-30-21)36-9-7-35(8-10-36)6-5-34(2)18-14-19-31-20(22-29-4-12-39-22)33-37(19)23(28)32-18;1-31(18-14-19-28-20(22-26-3-10-37-22)30-34(19)23(25)29-18)4-5-32-6-8-33(9-7-32)21-17(24)13-16(15-27-21)36-12-11-35-2;1-3-13-34-17-4-5-18(26-16-17)32-11-9-31(10-12-32)8-7-30(2)19-15-20-27-21(22-25-6-14-35-22)29-33(20)23(24)28-19/h4,12-15H,3,5-11H2,1-2H3,(H2,28,32);3,10,13-15H,4-9,11-12H2,1-2H3,(H2,25,29);4-6,14-16H,3,7-13H2,1-2H3,(H2,24,28)/i;2D3;
InChIKeyKZKRVELSRCMCHT-KLPANOOASA-N
MW1540.69 g/mol
LogP5.81
Rot. Bonds29

About 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine

7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine (PubChem CID 167610606) has the molecular formula C70H88F4N30O7 and a molecular weight of 1540.69 g/mol. Its IUPAC name is 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine.

Molecular Properties

Compound Name7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine
PubChem CID167610606
Molecular FormulaC70H88F4N30O7
Molecular Weight1540.69 g/mol
Exact Mass1539.76
IUPAC Name7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine
SMILESCCCOc1ccc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)nc1.CCCOc1ncc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)cc1C(F)(F)F.[2H]C([2H])([2H])OCCOc1cnc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)c(F)c1
InChIInChI=1S/C24H29F3N10O2.C23H29FN10O3.C23H30N10O2/c1-3-11-38-21-17(24(25,26)27)13-16(15-30-21)36-9-7-35(8-10-36)6-5-34(2)18-14-19-31-20(22-29-4-12-39-22)33-37(19)23(28)32-18;1-31(18-14-19-28-20(22-26-3-10-37-22)30-34(19)23(25)29-18)4-5-32-6-8-33(9-7-32)21-17(24)13-16(15-27-21)36-12-11-35-2;1-3-13-34-17-4-5-18(26-16-17)32-11-9-31(10-12-32)8-7-30(2)19-15-20-27-21(22-25-6-14-35-22)29-33(20)23(24)28-19/h4,12-15H,3,5-11H2,1-2H3,(H2,28,32);3,10,13-15H,4-9,11-12H2,1-2H3,(H2,25,29);4-6,14-16H,3,7-13H2,1-2H3,(H2,24,28)/i;2D3;
InChIKeyKZKRVELSRCMCHT-KLPANOOASA-N
XLogP5.81
TPSA390.14 Ų
H-Bond Donors3
H-Bond Acceptors37
Rotatable Bonds29
Heavy Atoms111
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001540.69
LogP ≤ 55.81
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine?
The IUPAC name of 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine (CID 167610606) is 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine.
What is the SMILES notation for 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine?
The canonical SMILES for 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine is CCCOc1ccc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)nc1.CCCOc1ncc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)cc1C(F)(F)F.[2H]C([2H])([2H])OCCOc1cnc(N2CCN(CCN(C)c3cc4nc(-c5ncco5)nn4c(N)n3)CC2)c(F)c1.
What is the InChIKey of 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine?
The InChIKey is KZKRVELSRCMCHT-KLPANOOASA-N. The full InChI is InChI=1S/C24H29F3N10O2.C23H29FN10O3.C23H30N10O2/c1-3-11-38-21-17(24(25,26)27)13-16(15-30-21)36-9-7-35(8-10-36)6-5-34(2)18-14-19-31-20(22-29-4-12-39-22)33-37(19)23(28)32-18;1-31(18-14-19-28-20(22-26-3-10-37-22)30-34(19)23(25)29-18)4-5-32-6-8-33(9-7-32)21-17(24)13-16(15-27-21)36-12-11-35-2;1-3-13-34-17-4-5-18(26-16-17)32-11-9-31(10-12-32)8-7-30(2)19-15-20-27-21(22-25-6-14-35-22)29-33(20)23(24)28-19/h4,12-15H,3,5-11H2,1-2H3,(H2,28,32);3,10,13-15H,4-9,11-12H2,1-2H3,(H2,25,29);4-6,14-16H,3,7-13H2,1-2H3,(H2,24,28)/i;2D3;.
What are the key properties of 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine?
7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine has a molecular weight of 1540.69 g/mol, XLogP of 5.81, 29 rotatable bonds, 3 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 7-N-[2-[4-[3-fluoro-5-[2-(trideuteriomethoxy)ethoxy]-2-pyridinyl]piperazin-1-yl]ethyl]-7-N-methyl-2-(1,3-oxazol-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-(5-propoxy-2-pyridinyl)piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine;7-N-methyl-2-(1,3-oxazol-2-yl)-7-N-[2-[4-[6-propoxy-5-(trifluoromethyl)-3-pyridinyl]piperazin-1-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine-5,7-diamine is sourced from PubChem (CID 167610606), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).